Strategic Advantages
- Experienced Leadership - MediQuest is led by experienced pharma-ceutical industry professionals. The Company's management team has had extensive prior experience in leading biotechnology/pharmaceutical companies, successfully creating shareholder value in these companies, in-licensing and out-licensing technologies and drug candidates, developing corporate partnerships, and managing the pharmaceutical discovery and clinical development process.
- Niche Specialty Pharma Model - MediQuest applies the proven specialty pharma business model in its selection and development of product candidates focused on skin diseases and conditions resulting from external attacks (e.g., infections) and internal, unregulated activations of the body's own defenses (e.g., inflammatory diseases). MediQuest's product candidates span the range from novel active agents, which require full FDA pharmaceutical regulatory approval, to novel formulation of generic active agents, which can be developed under the more rapid 505(b)(2) FDA guidelines.
- Large Target Markets - All of MediQuest's topical product targets address large pharmaceutical market opportunities with prospective annual revenues for each Company product candidate ranging from $200 to well over $500 million.
- Robust Pipeline - The MediQuest technology platforms have generated a product pipeline of therapeutics consisting of three drug candidates in late-stage clinical trials, one candidate at the pre-clinical stage, and others at the research stage. This robust product pipeline is expected to begin delivering sales revenues in 2007.
- Clinical Strengths - Clinical trials represent the major source of risk for specialty pharma companies. MediQuest mitigates that risk by engaging the world's leading medical clinicians as advisors in clinical trial design, entry and exclusion criteria, and study endpoints.
- Competitive Advantages - In addition to its aggressive intellectual property program, MediQuest enhances its competitive edge by only pursuing those opportunities where its product candidates will be First in Class and/or Best in Class.
- Core Technologies - MediQuest's robust product pipeline originates from the Company's strong chemistry, biology, and drug delivery technology platforms.
Contact Us
|
|
|
